The synthesis of human alpha-2-HS glycoprotein is down-regulated by cytokines in hepatoma HepG2 cells

FEBS Lett. 1988 Dec 5;241(1-2):191-4. doi: 10.1016/0014-5793(88)81059-7.

Abstract

The regulation of the synthesis of alpha-2-HS glycoprotein (AHSG) by inflammatory mediators from activated monocytes was studied on the human hepatoma cell line HepG2 and compared to that of albumin. Monocyte-conditioned medium, recombinant human interleukin-6 (rhIL6) and interleukin-1 beta (rhIL1 beta) all down-regulated the synthesis of AHSG. This decrease was found both at the protein and the mRNA level. The most efficient mediator was the monocyte-conditioned medium, when rhIL1 beta was found to be less efficient than rhIL6. The combination of rhIL6 and rhIL1 beta resulted in an additive down-regulation of the AHSG mRNA levels. Similar results were obtained with albumin. These data indicate that AHSG is a negative acute-phase protein whose synthesis is regulated by cytokines in a manner similar to that of albumin.

MeSH terms

  • Blood Proteins / biosynthesis*
  • Blood Proteins / genetics
  • Carcinoma, Hepatocellular / metabolism*
  • Cell Line
  • Humans
  • Interferon Type I / pharmacology*
  • Interleukin-4
  • Interleukin-6
  • Interleukins / physiology*
  • Liver Neoplasms / metabolism*
  • RNA, Messenger / drug effects
  • RNA, Messenger / genetics
  • Recombinant Proteins / pharmacology*
  • alpha-2-HS-Glycoprotein

Substances

  • AHSG protein, human
  • Blood Proteins
  • Interferon Type I
  • Interleukin-6
  • Interleukins
  • RNA, Messenger
  • Recombinant Proteins
  • alpha-2-HS-Glycoprotein
  • Interleukin-4